Isolated nucleic acid molecules useful in determining expression of a tumor rejection antigen precursor
US5612201A · kind A · utility
91Cited by
1References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 1, 1994 |
| Grant date | Mar 18, 1997 |
| Priority date | — |
| Expiry date | Sep 1, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/172
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to nucleic acid molecules which are useful in determining expression of the family of molecules known as the MAGE tumor rejection antigen precursors. These nucleic acid are molecules useful as diagnostic aids for determining whether or not an individual has cancer. Methods using these molecules are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.